Renal dysfunction improving drug comprising optical isomer of 1,4-benzothiazepine-1-oxide derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11844803
APP PUB NO 20200390782A1
SERIAL NO

16771877

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention addresses the problem of providing a pharmaceutical composition for treatment of a variety of conditions accompanied by renal dysfunction.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KANEKO NOBORU20-2-1205 EKIHIGASHIDORI 2-CHOME OYAMA-SHI TOCHIGI 3230022
AETAS PHARMA CO LTDTOKYO 103-0013

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kaneko, Noboru Oyama, JP 39 526

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 19, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 19, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 19, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00